These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32678173)

  • 41. Call to action for advocacy of immigrant nurses during COVID-19 pandemic.
    Tayaben JL; Younas A
    J Adv Nurs; 2020 Sep; 76(9):2220-2221. PubMed ID: 32431003
    [No Abstract]   [Full Text] [Related]  

  • 42. Is time our ultimate ally in defying the pandemic?
    Landoni G; Losi D; Fresilli S; Lazzari S; Nardelli P; Puglisi R; Zangrillo A
    Pathog Glob Health; 2020 Sep; 114(6):279-280. PubMed ID: 32594897
    [No Abstract]   [Full Text] [Related]  

  • 43. Assessment of patients who tested positive for COVID-19 after recovery.
    Mei Q; Li J; Du R; Yuan X; Li M; Li J
    Lancet Infect Dis; 2020 Sep; 20(9):1004-1005. PubMed ID: 32645295
    [No Abstract]   [Full Text] [Related]  

  • 44. In vitro volatile organic compound profiling using GC×GC-TOFMS to differentiate bacteria associated with lung infections: a proof-of-concept study.
    Nizio KD; Perrault KA; Troobnikoff AN; Ueland M; Shoma S; Iredell JR; Middleton PG; Forbes SL
    J Breath Res; 2016 Apr; 10(2):026008. PubMed ID: 27120170
    [TBL] [Abstract][Full Text] [Related]  

  • 45. COVID-19 pandemic, infodemic and the role of eHealth literacy.
    Chong YY; Cheng HY; Chan HYL; Chien WT; Wong SYS
    Int J Nurs Stud; 2020 Aug; 108():103644. PubMed ID: 32447127
    [No Abstract]   [Full Text] [Related]  

  • 46. Reevaluating limits of detection of 12 lateral flow immunoassays for the detection of Yersinia pestis, Francisella tularensis, and Bacillus anthracis spores using viable risk group-3 strains.
    Ziegler I; Vollmar P; Knüpfer M; Braun P; Stoecker K
    J Appl Microbiol; 2021 Apr; 130(4):1173-1180. PubMed ID: 32970936
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel Coronavirus 2019 (Sars-CoV2): a global emergency that needs new approaches?
    Perrella A; Carannante N; Berretta M; Rinaldi M; Maturo N; Rinaldi L
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):2162-2164. PubMed ID: 32141586
    [No Abstract]   [Full Text] [Related]  

  • 48. Special Issue on Diagnostic Testing for Severe Acute Respiratory Syndrome Coronavirus 2 and Lessons from This Pandemic.
    McAdam AJ
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32703896
    [No Abstract]   [Full Text] [Related]  

  • 49. Application of a portable instrument for rapid and reliable detection of SARS-CoV-2 infection in any environment.
    Martinelli F; Perrone A; Della Noce I; Colombo L; Lo Priore S; Romano S
    Immunol Rev; 2020 May; 295 Suppl s1(Suppl 1):4-10. PubMed ID: 32329102
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [COVID-19 and the 3 "P": Pandemic, Pediatrics and impact in the Country].
    Torres Torretti JP; O'Ryan Gallardo M
    Rev Chil Pediatr; 2020 Jun; 91(3):322-323. PubMed ID: 32730510
    [No Abstract]   [Full Text] [Related]  

  • 51. Covid-19 pandemic and the surge of panic attacks among NHS nursing staff: An ethnographical perspective.
    Lusher J; Murrell A; Mafuva C; Awire E
    J Adv Nurs; 2020 Nov; 76(11):2790-2791. PubMed ID: 32875665
    [No Abstract]   [Full Text] [Related]  

  • 52. Perfusion's Role in Responding to the COVID-19 Pandemic.
    Schiess JG
    J Extra Corpor Technol; 2020 Mar; 52(1):5-6. PubMed ID: 32280138
    [No Abstract]   [Full Text] [Related]  

  • 53. Will Coronavirus Disease 2019 Become Seasonal?
    Kanzawa M; Spindler H; Anglemyer A; Rutherford GW
    J Infect Dis; 2020 Aug; 222(5):719-721. PubMed ID: 32609334
    [TBL] [Abstract][Full Text] [Related]  

  • 54. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. COVID-19 Pandemic: Hopes from Proteomics and Multiomics Research.
    Ray S; Srivastava S
    OMICS; 2020 Aug; 24(8):457-459. PubMed ID: 32427517
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Resistant/susceptible classification of respiratory tract pathogenic bacteria based on volatile organic compounds profiling.
    Karami N; Rezadoost H; Mirzajani F; Karimi A; Ghassempour A; Aliahmadi A; Fallah F
    Cell Mol Biol (Noisy-le-grand); 2018 Jun; 64(9):6-15. PubMed ID: 30030949
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel Coronavirus (COVID-19): A Global Pandemic.
    Al-Dadah O; Hing C
    Knee; 2020 Mar; 27(2):279. PubMed ID: 32354423
    [No Abstract]   [Full Text] [Related]  

  • 58. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
    Richard K; Mann BJ; Qin A; Barry EM; Ernst RK; Vogel SN
    Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28077440
    [No Abstract]   [Full Text] [Related]  

  • 59. DNA nanoscaffold-based SARS-CoV-2 detection for COVID-19 diagnosis.
    Jiao J; Duan C; Xue L; Liu Y; Sun W; Xiang Y
    Biosens Bioelectron; 2020 Nov; 167():112479. PubMed ID: 32763826
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague.
    Tao P; Mahalingam M; Zhu J; Moayeri M; Sha J; Lawrence WS; Leppla SH; Chopra AK; Rao VB
    mBio; 2018 Oct; 9(5):. PubMed ID: 30327445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.